Mefloquine

Mefloquine is a medicine used to treat malaria, a disease caused by parasites. It's known by the brand name Lariam. It works by interfering with the parasites' ability to grow inside the body. It's usually taken as a pill.

Brand names:Lariam
Medication

What people taking Mefloquine report

Every report comes from a Lived member, sent anonymously.

Have you tried Mefloquine for Malaria?

NameHow it went

About Mefloquine

What It's For

Mefloquine is a prescription antimalarial tablet, used mainly to prevent malaria in people traveling to parts of the world where the disease is common. It can also treat mild to moderate malaria. It was first sold under the brand name Lariam, which is no longer marketed in the US; today it is available as generic mefloquine. Malaria is a parasite infection spread by mosquito bites, and one species, Plasmodium falciparum, can become life-threatening quickly. Mefloquine works against parasites that have become resistant to chloroquine, an older antimalarial, which is why it became widely used. It is taken only once a week, which suits long trips, and US travel guidance from the CDC (Centers for Disease Control and Prevention) names it as the only preventive medicine it recommends during pregnancy for areas where chloroquine no longer works. It can also be used while breastfeeding. It is not the right choice everywhere or for everyone. Malaria in parts of Southeast Asia, especially near the borders of Thailand, Myanmar and Cambodia, is resistant to mefloquine. Its psychiatric and neurologic side effects also rule it out for some people. Other preventive options include atovaquone-proguanil (Malarone), a daily tablet that can be started a day or two before travel, doxycycline, a daily antibiotic, and tafenoquine, a weekly adult-only option that requires a blood test first.

How It Works

Malaria parasites first settle in the liver, then move into red blood cells, where they multiply and cause fever and illness. Mefloquine attacks the parasites in the blood stage. Its exact mechanism is not fully understood. Because it does not kill parasites still sitting in the liver, prevention has to continue for four weeks after leaving a malaria area, to catch any parasites that emerge from the liver later. For the same reason, someone treated for Plasmodium vivax malaria, a type that can hide in the liver and relapse months later, needs a second medicine such as primaquine afterward. Mefloquine stays in the body a long time: about half of a dose is still present roughly three weeks later. That is what allows weekly dosing, but it also means side effects can start, or linger, for weeks after the last tablet.

Dosage & Administration

For prevention, adults take one 250 mg tablet once a week, on the same day each week. The CDC advises starting at least two weeks before travel, and some prescribers start three to four weeks early so any side effects show up before departure, while there is still time to switch. The weekly dose continues throughout the stay and for four weeks after leaving. Take each tablet after a meal rather than on an empty stomach, with a full glass of water. Children's doses are based on body weight, and tablets can be crushed and mixed into a little water, milk or another drink for those who cannot swallow them. Treatment of malaria uses a much larger dose over a short period, given under a clinician's direction. Mefloquine should not be used to treat malaria in someone who caught it while taking mefloquine for prevention.

Side Effects

Nausea, vomiting, loose stools, stomach pain, headache, dizziness, trouble sleeping and vivid or unusual dreams are among the more common effects. They often appear early, which is one reason to start before travel. The central concern, and the subject of a boxed warning from the US Food and Drug Administration (FDA), its most prominent type of safety alert, is neuropsychiatric effects: changes in mood, thinking or the nervous system. These can include anxiety, depression, restlessness, confusion, paranoia, hallucinations and, rarely, psychotic behavior or suicidal thoughts. Neurologic effects include dizziness or vertigo (a spinning sensation), ringing in the ears and loss of balance. Some people have had these symptoms continue for months or years after stopping, and in some cases they have been permanent. If any of these symptoms develop while taking mefloquine for prevention, stop it and contact the prescriber promptly to switch to a different antimalarial, so protection is not lost. Thoughts of suicide or self-harm need urgent help right away. Vision changes should also be reported, since rare eye problems affecting the retina or optic nerve have occurred. Until dizziness or balance problems resolve, avoid driving, flying a plane, operating machinery or scuba diving.

Interactions & Warnings

Mefloquine should not be used for prevention by people with active depression or depression in the recent past, generalized anxiety disorder, psychosis, schizophrenia or another major psychiatric condition, or by anyone with a history of seizures. It is also off limits for people allergic to mefloquine or the related drugs quinine and quinidine. It is not recommended for people with heart conduction problems, the electrical disturbances that affect heart rhythm. Two drugs must not be taken with mefloquine or for 15 weeks after the last dose, because together they can cause a dangerous heart rhythm problem: ketoconazole, an antifungal pill, and halofantrine, an antimalarial not sold in the US. Quinine, quinidine and chloroquine can add to heart rhythm and seizure risks. In people taking seizure medicines such as valproic acid, carbamazepine or phenytoin, mefloquine can lower their levels, so blood levels are checked. The live oral typhoid vaccine should be finished at least three days before the first mefloquine tablet. Mention any heart, diabetes or blood-thinning medicines before travel too. Liver disease can raise mefloquine levels and the chance of side effects. Rare liver injury has been reported, so long-term users have periodic liver tests and eye exams.

What to Expect

How a person will tolerate mefloquine is hard to predict in advance. Starting early gives a few weekly doses to see how it feels while there is still time to change plans. Pharmacies dispense a Medication Guide and a wallet card describing the warning signs, and the card is meant to be carried during treatment. No preventive medicine is fully protective. Insect repellent, covering clothing and bed nets still matter, and finishing the four weeks after travel matters as much as the doses taken during the trip. A fever during travel or in the months after returning needs medical care the same day, with a clear mention of where you traveled, even if every dose was taken. Malaria can progress quickly, and a blood test is the only way to rule it out.

Questions to Ask Your Doctor

  1. 1.Is mefloquine a good fit for my destination, or is there resistance where I am going?
  2. 2.Given my mental health and seizure history, would atovaquone-proguanil, doxycycline or tafenoquine be a safer choice?
  3. 3.How early should I start, so we can see how I tolerate it before I leave?
  4. 4.Do any of my current medicines or planned vaccines interact with mefloquine?
  5. 5.If I get side effects while abroad, what should I switch to and how do I get it?

Last reviewed • Oct 2026

Educational content, not medical advice.